| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.27B | 2.60B | 2.90B | 3.21B | 3.07B | 2.11B |
| Gross Profit | -77.09M | 34.18M | 316.20M | 793.27M | 813.18M | 34.21M |
| EBITDA | -133.72M | -36.64M | 306.48M | 813.12M | 695.48M | 147.50M |
| Net Income | -561.52M | -505.39M | -152.34M | 201.56M | 379.24M | -241.78M |
Balance Sheet | ||||||
| Total Assets | 4.86B | 5.41B | 6.27B | 5.85B | 4.04B | 2.85B |
| Cash, Cash Equivalents and Short-Term Investments | 29.04M | 8.10M | 62.93M | 224.06M | 413.26M | 14.54M |
| Total Debt | 2.81B | 3.40B | 3.69B | 3.14B | 2.56B | 2.18B |
| Total Liabilities | 4.69B | 5.05B | 5.35B | 4.79B | 3.21B | 2.83B |
| Stockholders Equity | 220.94M | 403.22M | 908.10M | 1.06B | 822.07M | 16.98M |
Cash Flow | ||||||
| Free Cash Flow | -88.34M | -111.57M | 5.69M | -58.83M | -228.16M | -52.82M |
| Operating Cash Flow | -3.55M | -103.33M | 224.47M | 715.30M | 435.30M | 6.58M |
| Investing Cash Flow | 201.89M | 280.47M | -718.51M | -1.16B | -650.26M | -57.80M |
| Financing Cash Flow | -222.68M | -232.57M | 332.57M | 272.77M | 593.86M | 55.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$4.47B | 7.86 | 9.36% | 6.70% | -3.73% | 6.09% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.30B | 20.16 | 2.46% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.18B | 16.45 | 3.61% | 2.20% | -8.51% | -68.34% | |
56 Neutral | HK$4.20B | 5.57 | 13.87% | ― | 9.20% | 213.87% | |
46 Neutral | HK$224.90M | -0.32 | -112.79% | ― | -22.72% | -212.73% |
Ko Yo Chemical (Group) Limited has provided an update on its going-concern status and related mitigation measures, highlighting ongoing efforts to manage its substantial bank debt through renewals, restructurings and repayments. The group has renewed or restructured about RMB394 million of bank loans, repaid roughly RMB51 million, secured RMB49 million in new borrowings, and is negotiating the renewal or restructuring of a further RMB231 million with the aim of extending repayment over three to five years. Operationally, the Dazhou plant completed shipment of its full 12,000-ton urea export quota in the fourth quarter, adding approximately RMB11.5 million in revenue, while the group has optimized its sales model by increasing the number of direct sales customers by 14 year-on-year. In addition, Ko Yo is continuing production optimization for its DMF and NMP projects at the Guang’an Ko Yo Electronic Materials Factory and is advancing the propylene oxide project at the Jiangsu Blue Planet factory into procedures handling and trial production preparation, signaling a push into higher-value chemical and electronic materials segments as part of its long-term stabilization and growth strategy.
The most recent analyst rating on (HK:0827) stock is a Hold with a HK$0.03 price target. To see the full list of analyst forecasts on Ko Yo Chemical (Group) Limited stock, see the HK:0827 Stock Forecast page.
Ko Yo Chemical (Group) Limited has provided supplemental disclosure regarding the emoluments of its Chief Executive Officer, Mr. Li Ciping, for the financial years 2017 and 2018. The announcement details specific compensations, including salaries, benefits, and pension contributions, for the period spanning May 2017 to July 2018. The report assures stakeholders that all other previously disclosed annual report information remains unchanged. This transparency in executive pay disclosures reflects the company’s adherence to corporate governance and regulatory compliance, which might positively impact its credibility and stakeholder confidence.
The most recent analyst rating on (HK:0827) stock is a Hold with a HK$0.03 price target. To see the full list of analyst forecasts on Ko Yo Chemical (Group) Limited stock, see the HK:0827 Stock Forecast page.
Ko Yo Chemical (Group) Limited has announced updates regarding its financial strategies and operational improvements as part of its annual report. The company has been actively negotiating with banks to restructure loans, aiming for a repayment schedule of 3 to 5 years. Additionally, the company has optimized its natural gas source at the Guangan plant, reducing production costs and increasing benefits. The Dazhou plant successfully shipped its export quota of urea, boosting revenue. The company is also enhancing its sales model by increasing direct sales customers and optimizing production at its Guang’an and Jiangsu factories. These measures are expected to strengthen the company’s financial position and operational efficiency.